These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36561903)

  • 1. Causes of pre-treatment loss to follow-up in patients with TB.
    Daka S; Matsuoka Y; Ota M; Hirao S; Phiri A
    Public Health Action; 2022 Dec; 12(4):148-152. PubMed ID: 36561903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study.
    Chilembo M; Oguri S; Matsuoka Y; Ota M; Musiankuni P; Kabungo J
    Public Health Action; 2020 Mar; 10(1):21-26. PubMed ID: 32368520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiologically Confirmed Tuberculosis: Factors Associated with Pre-Treatment Loss to Follow-Up, and Time to Treatment Initiation.
    Mwansa-Kambafwile J; Maitshotlo B; Black A
    PLoS One; 2017; 12(1):e0168659. PubMed ID: 28068347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriologically confirmed pulmonary tuberculosis patients: Loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012-2016.
    Mugauri H; Shewade HD; Dlodlo RA; Hove S; Sibanda E
    Int J Infect Dis; 2018 Nov; 76():6-13. PubMed ID: 30030177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What happened to patients with RMP-resistant/MDR-TB in Zambia reported as lost to follow-up from 2011 to 2014?
    Kasapo CC; Chimzizi R; Simwanza SC; Mzyece J; Chizema E; Mariandyshev A; Lee HY; Harries AD; Kapata N
    Int J Tuberc Lung Dis; 2017 Aug; 21(8):887-893. PubMed ID: 28786797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-treatment loss to follow-up and treatment delay among bacteriologically-confirmed tuberculosis patients diagnosed in Mandalay Region, Myanmar.
    Htwe KK; Kyaw NTT; Kumar AMV; Kyaw KWY; Oo MM; Thwin T; Saw S; Aung ST
    Trop Med Health; 2019; 47():30. PubMed ID: 31073273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
    Cox H; Dickson-Hall L; Ndjeka N; Van't Hoog A; Grant A; Cobelens F; Stevens W; Nicol M
    PLoS Med; 2017 Feb; 14(2):e1002238. PubMed ID: 28222095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-evaluated treatment outcomes of bacteriologically positive TB patients registered at a clinic in Lusaka, Zambia in 2018.
    Daka S; Matsuoka Y; Ota M; Hirao S; Phiri A
    Public Health Action; 2021 Mar; 11(1):22-25. PubMed ID: 33777717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment loss to follow-up among smear-positive TB patients in tertiary hospitals, Quetta, Pakistan.
    Wali A; Kumar AMV; Hinderaker SG; Heldal E; Qadeer E; Fatima R; Ullah A; Safdar N; Yaqoob A; Anwar K; Ul Haq M
    Public Health Action; 2017 Mar; 7(1):21-25. PubMed ID: 28775939
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.
    Muyoyeta M; Moyo M; Kasese N; Ndhlovu M; Milimo D; Mwanza W; Kapata N; Schaap A; Godfrey Faussett P; Ayles H
    PLoS One; 2015; 10(6):e0126376. PubMed ID: 26030301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Xpert MTB/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial.
    Cox HS; Mbhele S; Mohess N; Whitelaw A; Muller O; Zemanay W; Little F; Azevedo V; Simpson J; Boehme CC; Nicol MP
    PLoS Med; 2014 Nov; 11(11):e1001760. PubMed ID: 25423041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where, when, and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe.
    Murongazvombo AS; Dlodlo RA; Shewade HD; Robertson V; Hirao S; Pikira E; Zhanero C; Taruvinga RK; Andifasi P; Tshuma C
    Int J Infect Dis; 2019 Jan; 78():113-120. PubMed ID: 30368019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.
    Pan Afr Med J; ; . PubMed ID: 31308862
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.